VRTX vs MSFT: Which Stock is Better?
Side-by-side comparison of Vertex Pharmaceuticals Inc and Microsoft Corp in 2026
VRTX
Vertex Pharmaceuticals Inc
$496.83
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | VRTX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $126.19B | N/A | VRTX |
| P/E Ratio | 32.47 | 36.30 | VRTX |
| EPS (TTM) | $15.30 | $13.70 | VRTX |
| Revenue Growth | 0.1% | 14.9% | MSFT |
| Gross Margin | 53.7% | 68.8% | MSFT |
Analyze VRTX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is VRTX or MSFT a better investment?
Comparing VRTX and MSFT: Vertex Pharmaceuticals Inc has a market cap of $126.19B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between VRTX and MSFT?
VRTX (Vertex Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: VRTX or MSFT?
Based on P/E ratios, VRTX trades at a lower multiple (32.5x vs 36.3x).
Which is growing faster: VRTX or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.1% for VRTX.
Which company is more profitable: VRTX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 53.7% for VRTX.
Which is the larger company: VRTX or MSFT?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.19B compared to N/A for MSFT.
Should I buy VRTX or MSFT in 2026?
Both VRTX and MSFT have investment merit. VRTX trades at $496.83 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between VRTX and MSFT stock?
Key differences: Market Cap ($126.19B vs N/A), P/E Ratio (32.5x vs 36.3x), Revenue Growth (0.1% vs 14.9%), Gross Margin (53.7% vs 68.8%).